1.00419
Parteck® M 200 (Mannitol)
EMPROVE® ESSENTIAL, Ph. Eur., ChP, JP, USP, E 421
Synonym(s):
D-Mannitol
Select a Size
About This Item
Skip To
agency
BP
ChP
JP
Ph. Eur.
USP
Quality Level
product line
EMPROVE® ESSENTIAL
form
fine powder
autoignition temp.
410 °C
quality
E 421
particle size
(see specification)
bp
290-295 °C/4 hPa
mp
164-169 °C
solubility
213 g/L
application(s)
liquid formulation
pharmaceutical
solid formulation
storage temp.
2-25°C
SMILES string
OC(C(O)C(O)CO)C(O)CO
InChI
1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2
InChI key
FBPFZTCFMRRESA-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
1 of 4
This Item | 1.05980 | 1.37096 | 1.03668 |
|---|---|---|---|
| application(s) liquid formulation | application(s) liquid formulation | application(s) liquid formulation | application(s) liquid formulation |
| agency BP, JP, USP, ChP, Ph. Eur. | agency BP, ChP, JP, Ph. Eur., USP | agency BP, ChP, JP, Ph. Eur., USP | agency BP, JP, Ph. Eur., USP |
| form fine powder | form fine powder | form solid | form fine powder |
| product line EMPROVE® ESSENTIAL | product line EMPROVE® ESSENTIAL | product line EMPROVE® EXPERT | product line EMPROVE® EXPERT |
| solubility 213 g/L | solubility 213 g/L | solubility 213 g/L | solubility 213 g/L |
| autoignition temp. 410 °C | autoignition temp. 410 °C | autoignition temp. 410 °C | autoignition temp. - |
General description
As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.
Application
The specification of the product is part of the Emprove® Material Qualification Dossier and can be found under "General Properties".
Features and Benefits
- High compactibility at low compression forces
- Rapid disintegration and fast dissolution
- High dilution potential
- Non-hygroscopic, exceptionally low content of reducing sugars
- Uniform doses with homogenous distribution
Legal Information
used together
Storage Class
11 - Combustible Solids
wgk_germany
WGK 1
What is the Emprove® Program?
The Emprove® Program is a system providing comprehensive and thorough documentation of our filters and single-use components, pharma raw materials, and starting materials. Four document types are included with an Emprove® Program subscription:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
This article describes the advantages of mannitol when used as an excipient in solid drug formulation.
In recent years, mannitol has gained popularity as an excipient in solid dosage formulation due to its beneficial physicochemical properties.
Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.
Our overview of API solubility and dissolution enhancement methods can help you decide between the many options to take during formulation.
Related Content
Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service